Oncogene - Table of Contents alert Volume 31 Issue 10

TABLE OF CONTENTS Volume 31, Issue 10 (March 2012) In this issue Original Articles Short Communication Also new AOP Advertisement $89 Trial Size Antibodies and Free Kindle! $89 trial size primary antibodies for cancer, cell biology, cell signaling and neuroscience research. All guaranteed to give predictable, repeatable results. Spend $900 and receive a free Kindle! Protect your experiments with Rockland antibodies. Compromise elsewhere. Click here to choose your $89 trial size antibodies or browse our content-rich website at www.rockland-inc.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Reviews Genetics ANIMATION ON RNA INTERFERENCE Nature Reviews Genetics, in association with Arkitek Studios, has brought RNAi to life in this vivid, audio-visual journey into the cell. See RNAi in action by viewing the animation for FREE at: www.nature.com/nrg/multimedia/rnai Produced with support from Thermo Scientific   Original Articles Top Preferential selection of MnSOD transcripts in proliferating normal and cancer cells L Chaudhuri, A M Nicholson, A L Kalen and P C Goswami Oncogene 2012 31: 1207-1216; advance online publication, August 1, 2011; 10.1038/onc.2011.325 Abstract | Full Text Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death V Ratushny, H B Pathak, N Beeharry, N Tikhmyanova, F Xiao, T Li, S Litwin, D C Connolly, T J Yen, L M Weiner, A K Godwin and E A Golemis Oncogene 2012 31: 1217-1227; advance online publication, July 25, 2011; 10.1038/onc.2011.314 Abstract | Full Text Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma R D Eppinga, E W Krueger, S G Weller, L Zhang, H Cao and M A McNiven Oncogene 2012 31: 1228-1241; advance online publication, August 15, 2011; 10.1038/onc.2011.329 Abstract | Full Text Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers J Lee, L Li, N Gretz, J Gebert and S Dihlmann Oncogene 2012 31: 1242-1253; advance online publication, August 1, 2011; 10.1038/onc.2011.320 Abstract | Full Text Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation M Uemura, Q Zheng, C M Koh, W G Nelson, S Yegnasubramanian and A M De Marzo Oncogene 2012 31: 1254-1263; advance online publication, August 8, 2011; 10.1038/onc.2011.319 Abstract | Full Text PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma J R Molina, N K Agarwal, F C Morales, Y Hayashi, K D Aldape, G Cote and M-M Georgescu Oncogene 2012 31: 1264-1274; advance online publication, August 1, 2011; 10.1038/onc.2011.324 Abstract | Full Text An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling G Sala, S Traini, M D'Egidio, G Vianale, C Rossi, E Piccolo, R Lattanzio, M Piantelli, N Tinari, P G Natali, R Muraro and S Iacobelli on behalf of CINBO (Consorzio Interuniversitario Nazionale per la Bio-Oncologia) Oncogene 2012 31: 1275-1286; advance online publication, August 8, 2011; 10.1038/onc.2011.322 Abstract | Full Text 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma C Mackintosh, J L Ordóñez, D J García-Domínguez, V Sevillano, A Llombart-Bosch, K Szuhai, K Scotlandi, M Alberghini, R Sciot, F Sinnaeve, P C W Hogendoorn, P Picci, S Knuutila, U Dirksen, M Debiec-Rychter, K-L Schaefer and E de Álava Oncogene 2012 31: 1287-1298; advance online publication, August 8, 2011; 10.1038/onc.2011.317 Abstract | Full Text HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation S Haapa-Paananen, S Kiviluoto, M Waltari, M Puputti, J P Mpindi, P Kohonen, O Tynninen, H Haapasalo, H Joensuu, M Perälä and O Kallioniemi Oncogene 2012 31: 1299-1310; advance online publication, July 25, 2011; 10.1038/onc.2011.316 Abstract | Full Text DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD K Fu, H Ren, Y Wang, E Fei, H Wang and G Wang Oncogene 2012 31: 1311-1322; advance online publication, July 25, 2011; 10.1038/onc.2011.315 Abstract | Full Text JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms M Nakatake, B Monte-Mor, N Debili, N Casadevall, V Ribrag, E Solary, W Vainchenker and I Plo Oncogene 2012 31: 1323-1333; advance online publication, July 25, 2011; 10.1038/onc.2011.313 Abstract | Full Text Short Communication Top A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation C E Tognon, M J Martin, A Moradian, G Trigo, B Rotblat, S-W G Cheng, M Pollard, E Uy, C Chow, J M Carboni, M M Gottardis, M Pollak, G B Morin and P H B Sorensen Oncogene 2012 31: 1334-1340; advance online publication, August 1, 2011; 10.1038/onc.2011.323 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.